These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 18618100)
1. A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia. Sarter M; Martinez V; Kozak R Psychopharmacology (Berl); 2009 Jan; 202(1-3):237-58. PubMed ID: 18618100 [TBL] [Abstract][Full Text] [Related]
2. Detection of the moderately beneficial cognitive effects of low-dose treatment with haloperidol or clozapine in an animal model of the attentional impairments of schizophrenia. Martinez V; Sarter M Neuropsychopharmacology; 2008 Oct; 33(11):2635-47. PubMed ID: 18094665 [TBL] [Abstract][Full Text] [Related]
3. Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats. Kozak R; Martinez V; Young D; Brown H; Bruno JP; Sarter M Neuropsychopharmacology; 2007 Oct; 32(10):2074-86. PubMed ID: 17299502 [TBL] [Abstract][Full Text] [Related]
4. Sensitized attentional performance and Fos-immunoreactive cholinergic neurons in the basal forebrain of amphetamine-pretreated rats. Martinez V; Parikh V; Sarter M Biol Psychiatry; 2005 May; 57(10):1138-46. PubMed ID: 15866553 [TBL] [Abstract][Full Text] [Related]
5. Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats. Nelson CL; Burk JA; Bruno JP; Sarter M Psychopharmacology (Berl); 2002 May; 161(2):168-79. PubMed ID: 11981597 [TBL] [Abstract][Full Text] [Related]
6. Transient disruption of attentional performance following escalating amphetamine administration in rats. Kondrad RL; Burk JA Psychopharmacology (Berl); 2004 Oct; 175(4):436-42. PubMed ID: 15083258 [TBL] [Abstract][Full Text] [Related]
7. Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs. Barak S; Weiner I Int J Neuropsychopharmacol; 2009 Mar; 12(2):227-41. PubMed ID: 18687163 [TBL] [Abstract][Full Text] [Related]
8. More attention must be paid: the neurobiology of attentional effort. Sarter M; Gehring WJ; Kozak R Brain Res Rev; 2006 Aug; 51(2):145-60. PubMed ID: 16530842 [TBL] [Abstract][Full Text] [Related]
9. Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal. Russig H; Murphy CA; Feldon J Neuropsychopharmacology; 2002 Jun; 26(6):765-77. PubMed ID: 12007747 [TBL] [Abstract][Full Text] [Related]
10. Prepulse inhibition during withdrawal from an escalating dosage schedule of amphetamine. Russig H; Murphy CA; Feldon J Psychopharmacology (Berl); 2003 Sep; 169(3-4):340-53. PubMed ID: 12428150 [TBL] [Abstract][Full Text] [Related]
11. Amphetamine improves rat 5-choice continuous performance test (5C-CPT) irrespective of concurrent low-dose haloperidol treatment. Young JW; Roberts BZ; Breier M; Swerdlow NR Psychopharmacology (Berl); 2020 Jul; 237(7):1959-1972. PubMed ID: 32318751 [TBL] [Abstract][Full Text] [Related]
12. Augmented prefrontal acetylcholine release during challenged attentional performance. Kozak R; Bruno JP; Sarter M Cereb Cortex; 2006 Jan; 16(1):9-17. PubMed ID: 15788700 [TBL] [Abstract][Full Text] [Related]
13. [Cognition, schizophrenia and the effect of antipsychotics]. Stip E Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928 [TBL] [Abstract][Full Text] [Related]
14. Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin? Sarter M Psychopharmacology (Berl); 1994 May; 114(4):539-50. PubMed ID: 7855215 [TBL] [Abstract][Full Text] [Related]
15. Repeated pretreatment with amphetamine sensitizes increases in cortical acetylcholine release. Nelson CL; Sarter M; Bruno JP Psychopharmacology (Berl); 2000 Sep; 151(4):406-15. PubMed ID: 11026747 [TBL] [Abstract][Full Text] [Related]
16. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol. Gaisler-Salomon I; Weiner I Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023 [TBL] [Abstract][Full Text] [Related]
17. Haloperidol and clozapine have dissociable effects in a model of attentional performance deficits induced by blockade of NMDA receptors in the mPFC. Baviera M; Invernizzi RW; Carli M Psychopharmacology (Berl); 2008 Feb; 196(2):269-80. PubMed ID: 17940750 [TBL] [Abstract][Full Text] [Related]